• Room 02.018 - H.S.B Block 10 MBC Site

    United Kingdom

Accepting PhD Students

Willing to speak to media

19942019
If you made any changes in Pure these will be visible here soon.

Personal profile

Research Statement

The Stratified Medicine Group focuses on the following areas:

1) Characterisation of a molecular group in solid cancers that represents an innate immune response to DNA damage through the STING pathway.

2) Development of a biomarker for anti-angiogenic agents

3) Development of a biomarker for MEKK pathway activation

4) Identification of a prognostic biomarker for early prostate cancer

5) Development of new cell lines for pre-clinical modelling of ovarian and prostate cancer.

 

Other

Linked in Profile:

https://www.linkedin.com/in/profkennedy/

 

Fingerprint Dive into the research topics where Richard Kennedy is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 93 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
DNA Damage Medicine & Life Sciences
Biomarkers Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
Paraffin Medicine & Life Sciences
Formaldehyde Medicine & Life Sciences
Triple Negative Breast Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2012 2019

Research Output 1994 2019

A Novel Role for Cathepsin S as a Potential Biomarker in Triple Negative Breast Cancer

Wilkinson, R., Burden, R., McDowell, S., McArt, D., McQuaid, S., Bingham, V., Williams, R., Cox, O., O'Connor, R., McCabe, N., Kennedy, R., Buckley, N. E. & Scott, C., 28 Jun 2019, In : Journal of Oncology.

Research output: Contribution to journalArticle

Open Access
File
cathepsin S
Triple Negative Breast Neoplasms
Biomarkers
Neoplasms
DNA Repair
Tumor Biomarkers
Ulcerative Colitis
Colorectal Neoplasms
Cluster Analysis
Mutation

Defining the molecular evolution of extrauterine high grade serous carcinoma

Beirne, J. P., McArt, D. G., Roddy, A., McDermott, C., Ferris, J., Buckley, N. E., Coulter, P., McCabe, N., Eddie, S. L., Dunne, P. D., O'Reilly, P., Gilmore, A., Feeney, L., Ewing, D. L., Drapkin, R. I., Salto-Tellez, M., Kennedy, R. D., Harley, I. J. G., McCluggage, W. G. & Mullan, P. B., 04 Sep 2019, In : Gynecologic Oncology. 155, 2, p. 305-317 13 p.

Research output: Contribution to journalArticle

Molecular Evolution
Carcinoma
Fallopian Tubes
Carcinoma in Situ
Epithelium

DNA Repair Deficiency in Breast Cancer: Opportunities for Immunotherapy

Gilmore, E., McCabe, N., Kennedy, R. & Parkes, E., 19 Jun 2019, In : Journal of Oncology.

Research output: Contribution to journalArticle

Open Access
File
DNA Repair-Deficiency Disorders
Immunotherapy
Breast Neoplasms
Therapeutics
Tumor Microenvironment
2 Citations (Scopus)

High EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum

Hollis, R. L., Churchman, M., Michie, C. O., Rye, T., Knight, L., McCavigan, A., Perren, T., Williams, A. R. W., McCluggage, W. G., Kaplan, R. S., Jayson, G. C., Oza, A., Harkin, D. P., Herrington, C. S., Kennedy, R. & Gourley, C., 15 Aug 2019, In : Cancer. 125, 16, p. 2772-2781 10 p.

Research output: Contribution to journalArticle

Open Access
File
Platinum
Hypersensitivity
Carcinoma
Recombinational DNA Repair
Survival

Prizes

Queen’s University of Belfast Vice Chancellor Award for Innovation

Richard Kennedy (Recipient), 2013

Prize: Prize (including medals and awards)

St Luke’s Medal for Cancer Research. Royal College of Medicine, Ireland

Richard Kennedy (Recipient), 2015

Prize: Prize (including medals and awards)

Press / Media

Behind the Science. 30 minute TV programme on Cancer Research at QUB/Almac

Richard Kennedy

13/12/2017

1 media contribution

Press/Media: Public Engagement Activities

A visit to the Doctor in 2013. Public lecture.

Richard Kennedy

10/10/2017

1 item of media coverage

Press/Media: Public Engagement Activities

Impact

Development and Commercialization of a Technology Platform to Enable Biomarker Discovery and Validation

Richard Kennedy (Participant), Paul Harkin (Participant), Patrick Johnston (Participant), Alison Hosey (Participant), Julia Miskelly (Participant), Margaret Murray (Participant), Jennifer Quinn (Participant), Colin James (Participant), Jude Mulligan (Participant), Peter Daly (Participant), Paul Mullan (Participant), Julie Mussen (Participant), Ultan McDermott (Participant), Richard Wilson (Participant), Daniel Longley (Participant)

Impact: Health Impact, Quality of Life Impact